logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 12544335 B1

PDFFull Text
Date of Patent:
Feb. 10, 2026

Filed:

Jan. 28, 2022

Treatment approach by targeted delivery of bioactive molecules

Applicant:

Moroxite I Ab, Lund, SE;

Inventors:

Magnus Tägil, Lund, SE;

Deepak Bushan Raina, Lund, SE;

Lars Åke Alvar Lidgren, Lund, SE;

Assignee:

MOROXITE I AB, Lund, SE;

Attorney:

KNOBBE, MARTENS, OLSON & BEAR, LLP

Primary Examiner:

James W Rogers

Int. Cl.
CPC ...
A61K 9/14 (2006.01); A61K 9/00 (2006.01); A61K 9/51 (2006.01); A61K 31/4409 (2006.01); A61K 31/65 (2006.01); A61K 31/7036 (2006.01); A61K 31/704 (2006.01); A61K 38/08 (2019.01); A61K 51/12 (2006.01); A61L 27/18 (2006.01); A61L 27/20 (2006.01); A61L 27/36 (2006.01); A61L 27/46 (2006.01); A61L 27/54 (2006.01); A61L 27/58 (2006.01);
U.S. Cl.
CPC ...
A61K 9/143 (2013.01); A61K 9/0019 (2013.01); A61K 9/5115 (2013.01); A61K 31/4409 (2013.01); A61K 31/65 (2013.01); A61K 31/7036 (2013.01); A61K 31/704 (2013.01); A61K 38/08 (2013.01); A61K 51/1244 (2013.01); A61L 27/18 (2013.01); A61L 27/20 (2013.01); A61L 27/3608 (2013.01); A61L 27/365 (2013.01); A61L 27/46 (2013.01); A61L 27/54 (2013.01); A61L 27/58 (2013.01); A61L 2400/06 (2013.01); A61L 2400/12 (2013.01); A61L 2430/02 (2013.01);
Abstract

A method of treating a bacterial infection in a subject includes administering at least a first finely divided (particulate) material, which may have at least a second material, the first material is not bioresorbable or very slowly bioresorable and the second material or materials are bioresorbable at a higher rate than the first material, allowing a certain period of time to pass in order to provide for the first particulate material to be exposed to the body and/or second material or materials to be wholly or partly absorbed by the body of the subject, and administering one or more pharmaceutically active compounds. The first material is optionally pre-loaded or soaked with one or more pharmaceutically active compounds, and the second material is optionally pre-loaded or soaked with one or more pharmaceutically active compounds. The pharmaceutically active compound is a compound capable of treating or ameliorating a bacterial infection.

Find Patent Forward Citations

Loading…